NDC 70677-0153-01 - Ibuprofen Oral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70677-0153
- Requested NDC
- 70677-0153-01
- Package NDCs from labels
- 70677-0153-1, 70677-0153-01
- Manufacturer
- Strategic Sourcing Services | AptaPharma Inc.
- Effective date
- 2022-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) | Strategic Sourcing Services | AptaPharma Inc. | 2022-08-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70677-0153-1 | Ibuprofen Oral | 118 mL in 1 BOTTLE | SUSPENSION | 118 | 1 | |
| 70677-0153-1 | Ibuprofen Oral | 1 in 1 CARTON | SUSPENSION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70677-0153 | IBUPROFEN ORAL (IBUPROFEN ORAL) SUSPENSION [STRATEGIC SOURCING SERVICES] | 1 | Current NDC, Legacy NDC, 2 package rows | 20220811_a3062142-db0e-4758-a762-2b2bb05670b1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70677-0153-1 | ML - Milliliter | 70677-0153 | b4e8be0e-e5f7-4a79-9455-79aaa2fb6e4f | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Golden State Medical Supply, Inc. | 3ff501eb-5ae3-8824-e063-6394a90ac58e | 2025-11-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Brain Liquescence | GINKGO BILOBA, COLCHICUM AUTUMNALE, CONVALLARIA MAJALIS, NUX MOSCHATA, CEREBRUM (SUIS), AGARICUS MUSCARIUS, SCUTELLARIA LATERIFLORA, ANACARDIUM ORIENTALE, RIBOFLAVINUM, AMBRA GRISEA, BARYTA CARBONICA, GLYCERINUM | Nutritional Specialties, Inc. | a5c366f3-fd42-4602-b20b-b7b15fde564e | 2025-11-19 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 804d7b1f-1be8-50c9-e053-2a91aa0a35d0 | 2025-11-18 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f099a-ee59-0b9a-e053-2a95a90a2fe1 | 2025-11-18 | Warnings | WK2XYI10QM |
| IBUPROFEN | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f40f5-625d-3f2e-e053-2a95a90a438b | 2025-11-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f42a7-c2d8-4a51-e053-2a95a90a1677 | 2025-11-18 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f308f-0ca5-12fa-e053-2995a90a47fc | 2025-11-18 | Warnings | WK2XYI10QM |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | XF417D3PSL |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | WK2XYI10QM |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | WK2XYI10QM |
| good sense ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | c447fc6b-e9ef-447a-9609-5f893e18dfa7 | 2025-11-17 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Family Dollar Services Inc | 89ed9311-2185-4660-b219-9ea67b1a71ec | 2025-11-15 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Topco Associates, LLC | bcf7d4c1-1f99-48df-8f74-9abeefa8d41d | 2025-11-15 | Warnings | WK2XYI10QM |
| Antifungal cream | ANTIFUNGAL CREAM | Guangzhou Guoyoumi Biotechnology Co Ltd | 43a5b3c8-3b99-b113-e063-6394a90a9aff | 2025-11-15 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | L.N.K. International, Inc. | d1f20e10-0128-f2e5-1a03-6da5d7288a4e | 2025-11-15 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.